Investors were attracted to shares of corporate giants leading the Stargate Project, a joint venture aiming to create AI infrastructure to help develop a cancer vaccine. Shares rose for Oracle and SoftBank Group, two of the three key companies on the project, the third being OpenAI. Microsoft, Arm Holdings, and NVIDIA, technology partners of Stargate, also saw increased shares. Stargate plans to invest $500 billion over the next four years to build AI infrastructure at select US locations.
Alzheimer’s treatment: What’s next beyond amyloid?
In the face of rising global Alzheimer’s rates, a broader range of approaches towards finding a cure is in motion. Apart from the traditional approach
